GIP-mediated increase in circulating glucagon concentrations has been detected also in healthy humans, similar to preclinical studies this effect is glucose dependent, as it has been shown to occur only under hypoglycemia (113, 117). The gene discussed is GIP; the disease is Hypoglycemia.